Fortis Healthcare

Fortis Healthcare delivered a strong Q3 FY26 with consolidated revenue of INR 2,265 croreCurrent reported value: INR 2,265 crore. No comparable prior figure is available in the source record. (+17.5Current 17.5 crore vs previous available quarter 17.3 crore.% YoY) and EBITDA margin expansion of 290 bps to 22.3%Current reported value: 290 bps to 22.3%. No comparable prior figure is available in the source record., driven by hospital business growth of 19.4% and diagnostic margin recovery. Hospital ARPOB rose 4.5%Current reported value: 4.5%. No comparable prior figure is available in the source record. to INR 2.56 crCurrent INR 2.56 Cr. Reported change: +4.5% YoY.ore, supported by a 52%Current 52%. Reported change: +52% YoY. surge in robotic surgeries. Occupied beds grew 14% to 3,189Current 3,189. Reported change: +14% YoY., while occupancy held at 67%. The diagnostics business (Agilus) saw EBITDA margins improve to 23.1%Current 23.1%. Reported change: +870 bps YoY. from 14.4% YoY. Management guided for continued margin improvement via brownfield expansions (400+ beds next year, including FMRI) and cluster-based M&A (People Tree acquisition in Bengaluru). Risks include integration challenges at Gleneagles (negative 9M revenue growth) and potential dilution from IHH equity infusion.